• Study of the effectiveness and safety of tirzepatide for treating obesity in patients waiting for a liver transplant

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia

  • Study of aldesleukin in children aged 4 to 6 years with autism spectrum disorder whose mothers had immune system activation during pregnancy

    Not yet recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    France

  • Cannabidiol for behavioral problems in patients with Tuberous Sclerosis Complex, Sanfilippo syndrome, and Fragile X syndrome

    Not yet recruiting

    3 1 1
    Investigated drugs:
    The Netherlands

  • Study of ipilimumab, nivolumab, temozolomide and capecitabine in patients with chemotherapy-resistant metastatic colorectal cancer with specific genetic markers

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Safety and efficacy study of nadofaragene firadenovec administered to the renal pelvis in adults with low-grade upper tract urothelial carcinoma

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France The Netherlands Spain

  • Study comparing CHF 5993 (beclometasone/formoterol/glycopyrronium) to fluticasone/salmeterol inhalation in adolescents with uncontrolled asthma on medium-dose inhaled therapy

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Italy Spain

  • Study of Empagliflozin, Losartan Potassium and Hydrochlorothiazide to Prevent Kidney Stones in Patients with Paraffin Oil Induced Granulomatous Disease

    Not yet recruiting

    4 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Microdosing lysergide (20 µg) to improve symptoms, emotion regulation and sleep in adults with ADHD

    Not yet recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Total-Body PET with [18F]Flutemetamol in Patients with Post-COVID Syndrome (Long COVID)

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Short-course (7‑day) versus standard 14‑day ciprofloxacin treatment for men with serious urinary tract infection

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium

powered by